PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17307376-8	2007	RESULTS: GH treatment decreased hepatic triglyceride content and increased hepatic triglyceride secretion rate and serum cholesterol levels.	Triglycerides	40-52	growth hormone	Mus musculus	9-11	
19468705-0	2009	Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes.	Triglycerides	93-108	growth hormone	Mus musculus	0-14	
19468705-9	2009	In addition, growth hormone treatment resulted in improvement in glucose metabolism, with the highest dose normalising glucose, glucose tolerance and liver triacylglycerol.	Triglycerides	156-171	growth hormone	Mus musculus	13-27	
17307376-8	2007	RESULTS: GH treatment decreased hepatic triglyceride content and increased hepatic triglyceride secretion rate and serum cholesterol levels.	Triglycerides	83-95	growth hormone	Mus musculus	9-11	
11387232-5	2001	In LDLR mice, GH infusion reduced plasma cholesterol and triglycerides up to 40%, whereas HMG CoA reductase and C7alphaOH activities were stimulated by approximately 50% and 110% respectively.	Triglycerides	57-70	growth hormone	Mus musculus	14-16	
12563029-1	2003	Growth hormone (GH) acts on adipose tissue by accelerating fat expenditure, preventing triglyceride accumulation, and facilitating lipid mobilization.	Triglycerides	87-99	growth hormone	Mus musculus	0-14	
12563029-1	2003	Growth hormone (GH) acts on adipose tissue by accelerating fat expenditure, preventing triglyceride accumulation, and facilitating lipid mobilization.	Triglycerides	87-99	growth hormone	Mus musculus	16-18	
30910968-10	2019	We conclude that GH acts through its receptor in the liver to activate autophagy, preserve triglycerides, enhance gluconeogenesis, and prevent hypoglycemia in calorie-restricted mice, a model of famine.	Triglycerides	91-104	growth hormone	Mus musculus	17-19